​

Biodesix Ownership | Who Owns Biodesix?


OverviewForecastRevenueFinancialsChartTranscripts

Biodesix Ownership Summary


Biodesix is owned by 39.65% institutional investors, 40.13% insiders, and 20.22% retail investors. Aigh capital management is the largest institutional shareholder, holding 6.66% of BDSX shares. abrdn Healthcare Opportunities is the top mutual fund, with 2.73% of its assets in Biodesix shares.

BDSX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBiodesix39.65%40.13%20.22%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryDiagnostics & Research Stocks87.40%9.69%2.92%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Aigh capital management686.02K6.66%$20.46M
Soleus capital management416.60K5.52%$6.04M
Telemark asset management539.82K5.24%$16.10M
Birchview capital, lp286.80K3.91%$2.17M
Opaleye management238.05K3.15%$3.45M
Abrdn287.62K2.79%$8.58M
Vanguard group192.14K2.56%$1.31M
Marshall wace, llp141.64K1.88%$2.05M
Essex investment management132.09K1.75%$1.92M
Stempoint capital lp70.00K0.93%$1.02M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management686.02K2.06%$20.46M
Birchview capital, lp286.80K1.63%$2.17M
Perkins capital management61.34K1.31%$1.83M
Telemark asset management539.82K1.15%$16.10M
Amh equity651.87K0.98%$997.36K
Opaleye management238.05K0.45%$3.45M
Essex investment management132.09K0.30%$1.92M
Soleus capital management416.60K0.24%$6.04M
Thompson davis11.75K0.23%$350.51K
Stempoint capital lp70.00K0.20%$1.02M

Top Buyers

HolderShares% AssetsChange
Soleus capital management416.60K0.24%416.60K
Opaleye management238.05K0.45%238.05K
Marshall wace, llp141.64K0.00%141.64K
Essex investment management132.09K0.30%132.09K
Goldman sachs group118.03K-118.03K

Top Sellers

HolderShares% AssetsChange
Bryn mawr trust---6.10M
Birchview capital, lp286.80K1.63%-5.45M
Sio capital management---4.34M
Lmr partners llp---1.60M
Wells fargo & company/mn---819.90K

New Positions

HolderShares% AssetsChangeValue
Soleus capital management416.60K0.24%416.60K$6.04M
Opaleye management238.05K0.45%238.05K$3.45M
Marshall wace, llp141.64K0.00%141.64K$2.05M
Essex investment management132.09K0.30%132.09K$1.92M
Goldman sachs group118.03K-118.03K$180.59K

Sold Out

HolderChange
Western wealth management-1.00
Tower research capital llc (trc)-1.00
Gill capital partners-13.00
Group one trading-100.00
Bnp paribas arbitrage, snc-118.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026459.76%4,082,26312.91%392.83%26-16.13%13550.00%
Mar 31, 202615-42.31%2,294,90570.95%309.49%12-14.29%1-83.33%
Dec 31, 20255-81.48%504,482-64.86%61.84%2-71.43%1-95.00%
Sep 30, 20251-97.44%286,804-99.19%30.66%--100.00%1-90.00%
Jun 30, 202540-34.43%35,612,550-33.23%241.83%14-41.67%11-42.11%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
abrdn Healthcare Opportunities287.62K2.73%-
Vanguard Total Stock Mkt Idx Inv204.10K1.97%-
Vanguard Morn Total Stk Mkt Idx Investor204.10K1.97%-
Vanguard MStar Total Stk Mkt Idx Invest204.10K1.93%-
Vanguard US Total Market Shares ETF1.44M0.98%-
Vanguard Institutional Extnd Mkt Idx Tr72.03K0.68%-
1290 Essex Small Cap Growth I59.26K0.53%311.00
Pleiades Small Cap Equity A37.30K0.36%15.78K
Fidelity Extended Market Index27.54K0.25%-2.39K
iShares Micro-Cap ETF17.00K0.15%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 10, 2026SCHULER JACK W Emeritus DirectorBuy$1.00M
Aug 12, 2026SCHULER JACK W Emeritus DirectorBuy$366.99K
Aug 10, 2026SCHULER JACK W Emeritus DirectorBuy$337.03K
Aug 11, 2026SCHULER JACK W Emeritus DirectorBuy$328.91K
Feb 23, 2026Pestano Gary Anthony Chief Development OfficerSell$7.10K

Insider Transactions Trends


DateBuySell
2026 Q41-
2026 Q33-
2026 Q2--
2026 Q1315
2025 Q4-5

BDSX Ownership FAQ


Who Owns Biodesix?

Biodesix shareholders are primarily institutional investors at 39.65%, followed by 40.13% insiders and 20.22% retail investors. The average institutional ownership in Biodesix's industry, Diagnostics & Research Stocks, is 87.40%, which Biodesix falls below.

Who owns the most shares of Biodesix?

Biodesix’s largest shareholders are Aigh capital management (686.02K shares, 6.66%), Soleus capital management (416.6K shares, 5.52%), and Telemark asset management (539.82K shares, 5.24%). Together, they hold 17.42% of Biodesix’s total shares outstanding.

Does Blackrock own Biodesix?

BlackRock is not among the top 10 institutional shareholders of Biodesix.

Who is Biodesix’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Biodesix’s biggest shareholder by percentage of total assets invested, with 2.06% of its assets in 686.02K Biodesix shares, valued at 20.46M$.

Who is the top mutual fund holder of Biodesix shares?

abrdn Healthcare Opportunities is the top mutual fund holder of Biodesix shares, with 2.73% of its total shares outstanding invested in 287.62K Biodesix shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools